P3 Health Partners Inc.PIIINASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Latest News

businesswire.com

P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter.

defenseworld.net

P3 Health Partners (NASDAQ:PIII) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey

P3 Health Partners (NASDAQ: PIII - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, profitability and institutional ownership. Analyst Recommendations This is a

defenseworld.net

Financial Survey: Mobile-health Network Solutions (NASDAQ:MNDR) vs. P3 Health Partners (NASDAQ:PIII)

P3 Health Partners (NASDAQ: PIII - Get Free Report) and Mobile-health Network Solutions (NASDAQ: MNDR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Volatility and Risk P3 Health

defenseworld.net

KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey

P3 Health Partners (NASDAQ: PIII - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Risk and Volatility P3 Health

defenseworld.net

P3 Health Partners (NASDAQ:PIII) & CVR Medical (OTCMKTS:CRRVF) Head to Head Contrast

P3 Health Partners (NASDAQ: PIII - Get Free Report) and CVR Medical (OTCMKTS:CRRVF - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Volatility and Risk P3 Health Partners has

businesswire.com

P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners (“P3”) (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. This partnership brings together two highly aligned organizations with a shared belief in the power of pri.

newsfilecorp.com

P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Noble Capital Markets' 21st Annual Emerging Growth Equity Conference. Management is scheduled to present at the conference on Wednesday, December 3, 2025, at 3:30 p.m.

seekingalpha.com

P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript

P3 Health Partners Inc. ( PIII ) Q3 2025 Earnings Call November 14, 2025 8:00 AM EST Company Participants Aric Coffman - CEO, President & Director Amir Bacchus - Co-Founder, Chief Medical Officer & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Gabriella Gabel Joshua Raskin - Nephron Research LLC Ryan Langston - TD Cowen, Research Division David Larsen - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the P3 Health's Third Quarter 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

businesswire.com

P3 Health Partners Announces Third Quarter 2025 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. “Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model,” said Aric Coffman, CEO of P3. “Medical cost trends, normalized for prior-year adjustments, remain sta.

businesswire.com

P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webc.

businesswire.com

P3 Health Partners to Participate in the Jefferies Healthcare Services Conference

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services Conference. Management will participate in a fireside chat on Tuesday, September 30, 2025, at 2:25 PM Central Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3.

prnewswire.com

Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four States

GREENWOOD VILLAGE, Colo. , Aug. 25, 2025 /PRNewswire/ -- Catalyst Solutions is thrilled to announce the successful go-live of the Professional Health Partners Services (P3) Implementation, which officially launched in May 2025.

seekingalpha.com

P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript

P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Amir Bacchus - Co-Founder, Chief Medical Officer & Director Aric Coffman - CEO, President & Director Leif Pedersen - Chief Financial Officer Conference Call Participants Aaron Wukmir - Lake Street Capital Markets, LLC, Research Division David Michael Larsen - BTIG, LLC, Research Division Joshua Richard Raskin - Nephron Research LLC Ryan M. Langston - TD Cowen, Research Division Ryan K.

zacks.com

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago.

businesswire.com

P3 Health Partners Announces Second Quarter 2025 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. “Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan,” said Aric Coffman, CEO of P3. “While we faced prior period headwinds, we've successfully managed medical cost trends to remain flat while imp.

businesswire.com

P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, August 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/4:30pm ET the same day. Title & Webcast P3 Health Sec.

Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.

globenewswire.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance